KMB
48
3
NEM
36
2
DRI
53
8
STZ
50
5
ADBE
49
3
URI
62
2
AN
46
2
DLTR
24
4
DFS
71
7
CAH
40
2
GS
53
5
FMC
39
2
MAT
56
5
WFC
69
8
RCL
76
7
AKAM
56
2
LNC
58
9
AVGO
44
9
EXR
39
-5
DGX
31
-2
KMB
48
3
NEM
36
2
DRI
53
8
STZ
50
5
ADBE
49
3
URI
62
2
AN
46
2
DLTR
24
4
DFS
71
7
CAH
40
2
GS
53
5
FMC
39
2
MAT
56
5
WFC
69
8
RCL
76
7
AKAM
56
2
LNC
58
9
AVGO
44
9
EXR
39
-5
DGX
31
-2
Financhill
Back

Akero Therapeutics Vs. MoneyLion Industry Stock Comparison

Sell
44

AKRO
Akero Therapeutics

Last Price:
28.25
Seasonality Move:
-4.22%
Sell
30

ML
MoneyLion

Last Price:
39.68
Seasonality Move:
14.23%
Sell
44
Akero Therapeutics (AKRO) is a Sell

Is Akero Therapeutics a Buy, Sell or Hold?

  • The current Akero Therapeutics [AKRO] share price is $28.25. The Score for AKRO is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • AKRO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
MoneyLion (ML) is a Sell

Is MoneyLion a Buy, Sell or Hold?

  • The current MoneyLion [ML] share price is $39.64. The Score for ML is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • ML is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

AKRO Stock Price Chart

What is Akero Therapeutics's stock price today?

  • The Akero Therapeutics share price today is $28.25
    The current trend is moderately bullish and AKRO is experiencing slight selling pressure.

ML Stock Price Chart

What is MoneyLion's stock price today?

  • The MoneyLion share price today is $39.64
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ML is experiencing slight buying pressure.

AKRO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.62 Buy
Relative Strength Index (14 RSI): 54.87 Buy
Chaikin Money Flow: -181922 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (26.24 - 28.48) Buy
Bollinger Bands (100): (21.77 - 27.59) Buy

ML Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.27 Sell
Relative Strength Index (14 RSI): 43.45 Sell
Chaikin Money Flow: 47011 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.16 - 43.56) Sell
Bollinger Bands (100): (44.01 - 82.07) Sell

AKRO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.52 Sell
20-day SMA: 27.59 Buy
50-day SMA: 26.55 Buy
200-day SMA: 23.9 Buy
8-day EMA: 28.32 Sell
20-day EMA: 27.79 Buy
50-day EMA: 26.7 Buy
200-day EMA: 25.86 Buy

ML Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.24 Buy
20-day SMA: 40.91 Sell
50-day SMA: 46.17 Sell
200-day SMA: 62.35 Sell
8-day EMA: 39.36 Buy
20-day EMA: 41.14 Sell
50-day EMA: 47.54 Sell
200-day EMA: 55.05 Sell

Akero Therapeutics Earnings Growth & AKRO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.73 per share, and a decrease next year of $0.56 per share.

MoneyLion Earnings Growth & ML Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.82 per share, and an increase next year of $2.42 per share.

Akero Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

MoneyLion Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):